Analystreport

GlaxoSmithKline plc (NYSE: GSK) was upgraded by analysts at Societe Generale from a "sell" rating to a "buy" rating.

GSK plc American Depositary Shares (Each representing two Ordinary Shares)  (GSK) 
US:NYSE Investor Relations: gsk.com/en-gb/investors